Quincy Medical Center in the US has started a clinical trial to evaluate the Third Eye Retroscope, a device designed to detect colon cancer during colonoscopies.
The Third Eye, developed by Avantis Medical Systems, provides the doctors with a 360° image of the entire colon, enabling them to identify more abnormalities.
The device, which is smaller than the tip of a ballpoint pen refill, is contained within a typical colonoscope and acts as an additional scope.
Results from a previously conducted clinical study showed that Third Eye was able to detect 23.2% additional adenomas that would not have been found with the standard colonoscope alone.
The Third Eye Retroscope has received 510(k) approval from the US Food and Drug Administration.
Related Companies
